Loading clinical trials...
Loading clinical trials...
A Feasibility Study of Neurocognitive Evaluation in Patients Treated for Brain Metastases
RATIONALE: Assessment of patients undergoing radiation therapy may help to determine the effects of the treatment and may help improve cancer treatment. PURPOSE: This clinical trial is studying the memory skills in patients receiving radiation therapy for brain metastases.
OBJECTIVES: I. Determine the feasibility of performing a test battery consisting of five neurocognitive measures and a quality of life instrument following radiotherapy in patients with brain metastases. OUTLINE: Patients undergo radiotherapy 5 days a week for 3 weeks. Quality of life and neurocognitive function is assessed before study, at completion of radiotherapy, and at 1 month after completion of radiotherapy. Patients are followed at 1 month. PROJECTED ACCRUAL: A total of 50 patients will be accrued for this study over 5 months.
Age
0 - 120 years
Sex
ALL
Healthy Volunteers
No
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
Huntsville Hospital System
Huntsville, Alabama, United States
Comprehensive Cancer Institute of Huntsville
Huntsville, Alabama, United States
MBCCOP - Gulf Coast
Mobile, Alabama, United States
Alabama Oncology, LLC
Montgomery, Alabama, United States
Radiation Oncology Associates of West Alabama
Tuscaloosa, Alabama, United States
Providence Alaska Medical Center
Anchorage, Alaska, United States
Foundation for Cancer Research and Education
Phoenix, Arizona, United States
Arizona Cancer Center
Tucson, Arizona, United States
Mount Diablo Medical Center
Concord, California, United States
Start Date
November 1, 2000
Primary Completion Date
December 1, 2004
Completion Date
December 1, 2004
Last Updated
October 22, 2020
59
ACTUAL participants
management of therapy complications
PROCEDURE
quality-of-life assessment
PROCEDURE
Lead Sponsor
Radiation Therapy Oncology Group
Collaborators
NCT04657068
NCT04585750
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions